This appears to be a general principle that not only may contribute to the increased susceptibility of non‐O blood groups to cancer development but even explains the varying susceptibilities of the different ABO(H) phenotypes to special infectious diseases via trans‐species molecular complementarity. The gene discussed is ABO; the disease is infectious disease.